| 中文名 | F-9(美罗培南中间体) |
|---|---|
| 英文名 | (R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxyethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate |
| 中文别名 |
(3S,4R)-3-[(1R)-1-羟基乙基]-4-[(1R)-1-甲基-3-重氮-3-对硝基苄氧羰基-2-氧代丙基]氮杂环丁-2-酮
A9细胞(小鼠皮下结缔组织细胞)LM8C0018 F-9培南类主环中间体 罗恩 (R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 R162772 培南中间体 小鼠结缔组织L细胞株A9 美罗培南杂质5-14C 美罗培南杂质16 A9复合物 A9 细胞| A9 小鼠皮下结缔组织细胞 美罗培南中间体F9 美罗培南中间体F9(美罗培南中间体A9) A9细胞(JCRB) (3S,4R)-4-[(1R)-1-羟乙基]-3-[(1R)-1-甲基-3-重氮-3-对硝基苄基氧羰基-2-氧代 (R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 A9(小鼠皮下结缔组织细胞)YB-72018MC (3S,4R)-4-[(1R)-1-羟乙基]-3-[(1R)-1-甲基-3-重氮-3-对硝基苄基氧羰基-2-氧代丙基]-氮杂环丁基酮-2 A-9小鼠皮下结缔组织复苏细胞(附STR鉴定报告) |
| 英文别名 |
Mouse S100A8
Meropenem intermediate F9 (4R)-2-diazonio-4-[(2R,3S)-3-[(1R)-1-hydroxyethyl]-4-oxoazetidin-2-yl]-1-[(4-nitrophenyl)methoxy]-1-oxopent-2-en-3-olate (3S,4R)-3-[(1R)-1-Hydroxyethyl]-4-[(1R)-1-methyl-3-diazo-3-(p-nitrobenzyloxycbonyl)-2-oxopropyl]azetidin-2-one //BP (R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoa MeropeneM InterMediates(F-9) Intermediate F9 of Meropenem 4-Nitrobenzyl (4R)-2-diazo-4-{(2R,3S)-3-[(1R)-1-hydroxyethyl]-4-oxo-2-azetidinyl}-3-oxopentanoate 2-Azetidinebutanoic-a-14C acid, a-diazo-3-(1-hydroxyethyl)-g-methyl-b,4-dioxo-,(4-nitrophenyl)methyl ester, [2R-[2a(R*),3b(R*)]]- (9CI) F9(A9) A9 elisa kit (3S,4R)-3-[(1R)-1-Hydroxyethyl]-4-[(1R)-1-methyl-3-diazo-3-(p-nitrobenzyloxycbonyl)-2-oxopropyl]azetidin-2-one (3S,4R)-3-[(1R)-1-Hydroxyethyl]-4-[(1R)-1-Methyl-3-diazo-3-(p-nitrobenzyloxycbonyl)-2-oxopropyl]az (A9) (3S,4R)-3-[(1R)-1-Hydroxyethyl]-4-[(1R)-1-methyl-3-diazo-3-(4-nitrobenzyloxycbonyl)-2-oxopropyl]azetidin-2-one Human S100 Calcium Binding Protein A8 (S100A8 Meropenem impurity c (R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate |
| 分子式 | C17H18N4O7 |
|---|---|
| 分子量 | 390.347 |
| 精确质量 | 390.117554 |
| PSA | 175.91000 |
| LogP | -2.02 |
| 储存条件 | -196°C |
| 危害码 (欧洲) | Xi |
|---|